Anavex Life Sciences Corp. (0HFR.L) LSE
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 758.22M |
| Enterprise Value | 655.65M |
| P/E Ratio | -7.03 |
| PEG Ratio | -0.21 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 2.09 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -3.87 |
Fiscal Year
| Fiscal Year | September 30, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | 0 |
| Operating Margin | 0 |
AD
Management Effectiveness
| Return On Assets | -0.26 |
| Return On Equity | -0.31 |
Income Statement
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | 0 |
| EBITDA | -47.03M |
| Net Income | -46.38M |
| Diluted EPS | -0.54 |
Balance Sheet
| Total Cash | 127.42M |
| Total Cash/Share | 1.37 |
| Total Debt | 0 |
| Total Debt/Equity | 0 |
| Current Ratio | 18.24 |
| Book Value Per Share | 1.31 |
Price History
| 52-Week Change | -74.77 |
| 52-Week High | 10.45 |
| 52-Week Low | 2.66 |
| Moving Average 50 Days | 5.79 |
| Moving Average 200 Days | 7.24 |
Statistics
| Average Volume | 7,784 |
| Shares Outstanding | 92.65M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
